Free Trial
LON:MXC

Argent BioPharma (MXC) Share Price, News & Analysis

Argent BioPharma logo

About Argent BioPharma Stock (LON:MXC)

Key Stats

Today's Range
N/A
50-Day Range
22
22
52-Week Range
N/A
Volume
264 shs
Average Volume
26,353 shs
Market Capitalization
£9.65 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

MGC Pharmaceuticals Limited provides phytomedicines worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. In addition, the company provides Irnican that is in preclinical phase for the tetrahydrocannabinol, as well as offers ArtemiC and non-pharma products. Further, it offers consulting services, including clinical research services. MGC Pharmaceuticals Limited was founded in 2014 and is based in Subiaco, Australia.

Receive MXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Argent BioPharma and its competitors with MarketBeat's FREE daily newsletter.

MXC Stock News Headlines

Argent BioPharma Ltd (RGT)
Charles Payne Wants You Prepared for Q4
Charles Payne Wants You Prepared for Q4 Because as we look toward 2025, there's no denying that market volatility, inflation, and recession fears are top of mind for every investor Now more than ever, it's crucial to have a solid plan for navigating uncertainty and coming out ahead.
MGC Pharmaceuticals Ltd (MXC)
MGC Pharmaceuticals Ltd MXC
MGC Pharma receives Saudi approval for ArtemiC
See More Headlines

MXC Stock Analysis - Frequently Asked Questions

Shares of MXC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Argent BioPharma investors own include Rolls-Royce Holdings plc (RR), Argo Blockchain (ARB), AutoZone (AZO), BP (BP), Chaarat Gold (CGH), Diageo (DGE) and EQTEC (EQT).

Industry, Sector and Symbol

Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Petroleum And Natural Gas
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Net Income
£-17,020,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.32 million
Book Value
GBX 4 per share

Miscellaneous

Free Float
N/A
Market Cap
£9.65 million
Optionable
Not Optionable
Beta
1.03
7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

This page (LON:MXC) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners